Neuronetics, Inc. (STIM) financial statements and ratios from SEC XBRL: revenue $149.16M (TTM), net margin -26.1%, revenue growth 99.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $149.16M |
| Net Margin | -26.1% |
| Revenue Growth (YoY) | 99.2% |
| EPS Growth (YoY) | -57.2% |
| FCF Growth (YoY) | -34.8% |
| Price / Book | 9.94 |
| Price / Sales | 1.46 |
| FCF Yield | -14.1% |
| Altman Z-Score | -2.84 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.6 |
STIM overview · STIM earnings · STIM KPIs · STIM investor relations · STIM ownership · STIM peers · STIM filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.